Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.

The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the 24 month contract duration and the 24 month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 32662. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework. Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/). (SC Ref:841676)

Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of infliximab subcutaneous injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of adalimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 7 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of golimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of infliximab intravenous infusion to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 6 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of omalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of tocilizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of ustekinumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 9 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Supply of tildrakizumab to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Public Contracts Regulations 2015 (Directive 2014/24/EU)

Open procedure

https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000841676